EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:755741 - plozalizumab
| ChEBI ID | CHEBI:755741 |
| ChEBI Name | plozalizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Role: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | hypoglycemic agent A drug which lowers the blood glucose level. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| plozalizumab (CHEBI:755741) has role antiatherosclerotic agent (CHEBI:145947) |
| plozalizumab (CHEBI:755741) has role antineoplastic agent (CHEBI:35610) |
| plozalizumab (CHEBI:755741) has role cardiovascular drug (CHEBI:35554) |
| plozalizumab (CHEBI:755741) has role hypoglycemic agent (CHEBI:35526) |
| plozalizumab (CHEBI:755741) has role immunosuppressive agent (CHEBI:35705) |
| plozalizumab (CHEBI:755741) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| plozalizumab | WHO MedNet |
| Synonyms | Source |
|---|---|
| hu1D9 | ChEMBL |
| HU-1D9 | ChEMBL |
| MLN-1202 | ChEMBL |
| MLN1202 | ChEMBL |